Jun 11, 2010 NeoPharm, Inc. Announces First Quarter 2010 Financial Results and Clinical Trial Update
May 17, 2010 NeoPharm Announces FDA Grant of Orphan Drug Designation for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary Fibrosis
View all releases »
